Sequential proteolytic processing of an interferon-alpha receptor subunit by TNF-alpha converting enzyme and presenilins

Journal of Interferon and Cytokine Research

Volumn 32, Issue 7, 2012, Pages 312-325

  Pioli, Peter D ^a   Saleh, Abu M Z ^a   El Fiky, Ashraf ^a   Nastiuk, Kent L ^a,b   Krolewski, John J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR SUBUNIT 2; EPITOPE; HYBRID PROTEIN; PRESENILIN 1; PRESENILIN 2; PROTEIN VARIANT; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL NUCLEUS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SUBUNIT; SIGNAL TRANSDUCTION;

ADAM PROTEINS; ANIMALS; CELL LINE; CELL PROLIFERATION; CHO CELLS; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEK293 CELLS; HUMANS; MICE; PRESENILINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, INTERFERON ALPHA-BETA; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 84863792524     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0116     Document Type: Article

References (54)

1. Arribas J, Borroto A. 2002. Protein ectodomain shedding. Chem Rev 102:4627-4638.
2. Baumann G, Frank SJ. 2002. Metalloproteinases and the modulation of GH signaling. J Endocrinol 174:361-368.
3. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. 1997.a metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729-733.
4. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA, Israel A. 2000. A novel proteolytic cleavage involved in Notch signaling: The role of the disintegrin-metalloprotease TACE. Mol Cell 5:207-216.
5. Brown MS, Ye J, Rawson RB, Goldstein JL. 2000. Regulated intramembrane proteolysis: A control mechanism conserved from bacteria to humans. Cell 100:391-398.
6. Ceballos MP, Parody JP, Alvarez MD, Ingaramo PI, Carnovale CE, Carrillo MC. 2011. Interferon-alpha2b and transforming growth factor-beta1 treatments on HCC cell lines: Are Wnt/ beta-catenin pathway and Smads signaling connected in hepatocellular carcinoma? Biochem Pharmacol 82:1682-1691.
7. Chill JH, Quadt SR, Levy R, Schreiber G, Anglister J. 2003. The human type I interferon receptor: nmr structure reveals the molecular basis of ligand binding. Structure 11:791-802.
8. Colamonici OR, Uyttendaele H, Domanski P, Yan H, Krolewski JJ. 1994a. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J Biol Chem 269:3518-3522.
9. Colamonici OR, Yan H, Domanski P, Handa R, Smalley D, Mullersman J, Witte M, Krishnan K, Krolewski JJ. 1994b. Direct binding and tyrosine phosphorylation of the a-subunit of the type I IFN receptor by the p135tyk2 tyrosine kinase. Mol Cell Biol 14:8133-8142.
10. Conte F, Salles JP, Raynal P, Fernandez L, Molinas C, Tauber M, Bieth E. 2002. Identification of a region critical for proteolysis of the human growth hormone receptor. Biochem Biophys Res Commun 290:851-857.
11. Cowan J, Wang X, Guan R, He K, Jiang J, Baumann G, Black RA, Wolfe MS, Frank SJ. 2005. GH receptor is a target for presenilin-dependent gamma -secretase cleavage. J Biol Chem 280:19331-19342.
12. Darnell JE. 1997. STATs and gene regulation. Science 277:1630-1635.
13. Darnell JE, Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
14. Davis E, Krishnan K, Yan H, Newcomb E, Krolewski JJ. 1996.a mutant form of p135tyk2, an interferon-alpha inducible tyrosine kinase, can suppress tumorigenicity. Leukemia 10: 543-551.
15. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R. 1999. A presenilin-1-dependent gammasecretase-like protease mediates release of Notch intracellular domain. Nature 398:518-522.
16. Domanski P, Fish E, Naduea OW, Witte M, Platanias LC, Yan H,rolewski J, Pitha P, Colamonici OR. 1997. A region of the ß subunit of the interferon alpha receptor different from Box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state. J Biol Chem 272:26388-26393.
17. Edwards DR, Handsley MM, Pennington CJ. 2008. The ADAM metalloproteinases. Mol Aspects Med 29:258-289.
18. El Fiky A, Arch AE, Krolewski JJ. 2005. The intracellular domain of the IFNaR2 interferon receptor subunit mediates transcription via Stat2. J Cell Physiol 204:567-573.
19. El Fiky A, Pioli P, Azam A, Yoo K, Nastiuk KL, Krolewski JJ. 2008. Nuclear transit of the intracellular domain of the interferon receptor subunit IFNaR2 requires Stat2 and Irf9. Cell Signal 20:1400-1408.
20. Erickson S, Sangfelt O, Castro J, Heyman M, Einhorn S, Grander D. 1999. Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins. Cell Growth Differ 10:575-582.
21. Firmbach-Kraft I, Byers M, Shows T, Dalla-Favera R, Krolewski JJ. 1990. tyk2, prototype of a novel class of non-receptor tyrosinekinase genes. Oncogene 5:1329-1336.
22. Glenn G, van der Geer P. 2007. CSF-1 and TPA stimulate independent pathways leading to lysosomal degradation or regulated intramembrane proteolysis of the CSF-1 receptor. FEBS Lett 581:5377-5381.
23. Gossen M, Bujard H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89:5547-5551.
24. Gupta S, Yan H, Wong LH, Ralph S, Krolewski JJ, Schindler CW. 1996. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-a signals. EMBO J 15:1075-1084.
25. Hemming ML, Elias JE, Gygi SP, Selkoe DJ. 2008. Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements. PLoS Biol 6:e257.
26. Jordan M, Wurm F. 2004. Transfection of adherent and suspended cells by calcium phosphate. Methods 33:136-143.
27. Kimberly WT, LaVoie MJ, Ostaszewski BL, Ye W, Wolfe MS, Selkoe DJ. 2003. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci U S A 100:6382-6387.
28. Kimberly WT, Xia W, Rahmati T, Wolfe MS, Selkoe DJ. 2000. The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation. J Biol Chem 275:3173-3178.
29. Krishnan K, Pine R, Krolewski JJ. 1997. Kinase-deficient forms of Jak1 and Tyk2 inhibit interferon alpha signaling in a dominant manner. Eur J Biochem 247:298-305.
30. Lal M, Caplan M. 2011. Regulated intramembrane proteolysis: Signaling pathways and biological functions. Physiology (Bethesda) 26:34-44.
31. Lutfalla G, Holland SJ, Cinato E, Monneron D, Reboul J, Rogers NC, Smith JM, Stark GR, Gardiner K, Mogensen KE, Kerr IM, Uzé G. 1995. Mutant U5A cells are complemented by an interferon-ab receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J 14:5100-5108.
32. Marcantonio EE, Hynes RO. 1988. Antibodies to the conserved cytoplasmic domain of the integrin beta 1 subunit react with proteins in vertebrates, invertebrates, and fungi. J Cell Biol 106:1765-1772.
33. Marin P, Nastiuk KL, Daniel N, Girault JA, Czernik AJ, Glowinski J, Nairn AC, Premont J. 1997. Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. J Neurosci 17:3445-3454.
34. Mogensen KE, Lewerenz M, Reboul J, Lutfalla G, Uzé G. 1999. The type I interferon receptor: Structure, function, and evolution of a family business. J Interferon Cytokine Res 19:1069-1098.
35. Montero JC, Yuste L, Diaz-Rodriguez E, Esparis-Ogando A, Pandiella A. 2002. Mitogen-activated protein kinasedependent and -independent routes control shedding of transmembrane growth factors through multiple secretases. Biochem J 363:211-221.
36. Nguyen V-P, Saleh AZM, Arch AE, Yan H, Piazza F, Kim J, Krolewski JJ. 2002. Stat2 binding to the interferon alpha receptor 2 (IFNaR2) subunit is not required for interferon-alpha signaling. J Biol Chem 277:9713-9721.
37. Ni CY, Murphy MP, Golde TE, Carpenter G. 2001. Gammasecretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294:2179-2181.
38. Romerio F, Zella D. 2002. MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB J 16: 1680-1682.
39. Saleh AZ, Nguyen VP, Krolewski JJ. 2002. Affinity of Stat2 for the subunits of the interferon alpha receptor. Biochemistry 41:11261-11268.
40. Saleh AZM, Arch AE, Neupane D, Krolewski JJ. 2004. Regulated proteolysis of the IFNaR2 subunit of the interferon-alpha receptor. Oncogene 23:7076-7086.
41. Schroeter EH, Kisslinger JA, Kopan R. 1998. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393:382-386.
42. Uddin S, Sassano A, Deb DK, Verma A, Majchrzak B, Rahman A, Malik AB, Fish EN, Platanias LC. 2002. Protein kinase C-delta is activated by type I interferons and mediates phosphorylationof Stat1 on serine 727. J Biol Chem 277:14408-14416.
43. Vecchi M, Baulida J, Carpenter G. 1996. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J Biol Chem 271:18989-18995.
44. Vecchi M, Carpenter G. 1997. Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism. J Cell Biol 139:995-1003.
45. Weskamp G, Schlondorff J, Lum L, Becherer D, Kim TW, Saftig P, Hartmann D, Murphy G, Blobel CP. 2004. Evidence for a critical role of the TNFalpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem 279:4241-4249.
46. Wilhelmsen K, van der Geer P. 2004. Phorbol 12-myristate 13-acetate-induced release of the colony-stimulating factor 1 receptor cytoplasmic domain into the cytosol involves two separate cleavage events. Mol Cell Biol 24:454-464.
47. Wilks AF, Harpur AG, Kurban RR, Ralph SJ, Zurcher G, Ziemiecki A. 1991. Two novel protein-tyrosine kinases, each with a second phosphotransferase- related catalytic domain, define a new class of protein kinases. Mol Cell Biol 11:2057-2065.
48. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. 1999. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398:513-517.
49. Xu P, Derynck R. 2010. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell 37:551-566.
50. Yan H, Krishnan K, Greenlund AC, Gupta S, Lim JTE, Schreiber RD, Schindler C, Krolewski JJ. 1996a. Phosphorylated interferonalpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kD STAT2 protein. EMBO J 15:1064-1074.
51. Yan H, Krishnan K, Lim JTE, Contillo LG, Krolewski JJ. 1996b. Molecular characterization of an IFNaR1 domain required for TYK2 binding and signal transduction. Mol Cell Biol 16:2074-2082.
52. Zhang Y, Guan R, Jiang J, Kopchick JJ, Black RA, Baumann G, Frank SJ. 2001. Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis. J Biol Chem 276:24565-24573.
53. Zhang Y, Jiang J, Black RA, Baumann G, Frank SJ. 2000. Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: The metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 141: 4342-4348.
54. Zhou W, Carpenter G. 2000. Heregulin-dependent trafficking and cleavage of ErbB-4. J Biol Chem 275:34737-34743.